K Number
K083882
Device Name
MYLABFIVE
Manufacturer
Date Cleared
2009-01-30

(32 days)

Product Code
Regulation Number
892.1550
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Esaote's MyLabFive is a compact ultrasound system used to perform diagnostic general ultrasound studies including Cardiac, Transesophageal, Peripheral Vascular, Neonatal Cephalic, Adult Cephalic, Small organ, Musculoskeletal (Conventional and Superficial). Abdominal, Fetal, Transvaginal, Transrectal, Pediatric, Laparoscopic, Intraoperative Abdominal, and Other Urologic. The system provides imaging for guidance of biopsy and imaging to assist in the placement of needles and catheters in vascular or other anatomical structures as well as peripheral nerve blocks in Musculoskeletal applications.
Device Description
The MyLabFive is a portable ultrasound system used to perform diagnostic general ultrasound studies. Its primary modes of operation are: B-Mode. M-Mode, Multi View (MView), Amplitude Doppler (AD), Tissue Velocity Mapping (TVM) and Tissue Enhancement Imaging (TEI). Optional is Doppler and Color Flow Mapping (CFM). The MyLabFive is equipped with a LCD Color Display. The full alphanumeric keyboard allows complete on-screen data entry of patient information and on-screen annotations. The MyLabFive can drive phased (PA), convex (CA), linear array (LA) and Doppler probes. The MyLabFive is equipped with an internal Hard Disk and with an optional external DVD-RW disk drive that can be used for image storage. Data can also be stored directly to external archiving media (hard-disk, PC, server) via a LAN/USB port. Optional accessory devices available for the MyLabFive include an S-VHS video recorder, a monochrome or color page printer and a mobile trolley equipped with an insulation transformer.
More Information

No
The document describes standard ultrasound imaging modes and hardware components without mentioning any AI or ML capabilities.

No
The device is described as a "diagnostic general ultrasound system" used for imaging, guidance of biopsy, and assist in placement of needles and catheters. Its described functions are for diagnosis and guidance, not for treating conditions.

Yes
The "Intended Use / Indications for Use" section explicitly states that the device is "used to perform diagnostic general ultrasound studies".

No

The device description clearly outlines hardware components such as probes, a display, a keyboard, a hard disk, and optional external drives and printers, indicating it is a physical ultrasound system, not software only.

Based on the provided information, the Esaote MyLabFive is not an In Vitro Diagnostic (IVD) device.

Here's why:

  • IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for diagnostic purposes.
  • MyLabFive Function: The MyLabFive is an ultrasound system. It uses sound waves to create images of internal body structures. It does not analyze specimens taken from the body. Its function is based on imaging the body directly.

The intended use and device description clearly indicate that the MyLabFive is used for in vivo (within the living body) diagnostic imaging studies.

N/A

Intended Use / Indications for Use

Esaote's MyLabFive is a compact ultrasound system used to perform diagnostic general ultrasound studies including Cardiac, Transesophageal, Peripheral Vascular, Neonatal Cephalic, Adult Cephalic, Small organ, Musculoskeletal (Conventional and Superficial). Abdominal, Fetal, Transvaginal, Transrectal, Pediatric, Laparoscopic, Intraoperative Abdominal, and Other Urologic. The system provides imaging for guidance of biopsy and imaging to assist in the placement of needles and catheters in vascular or other anatomical structures as well as peripheral nerve blocks in Musculoskeletal applications.

Product codes

IYN, IYO, ITX

Device Description

The MyLabFive is a portable ultrasound system used to perform diagnostic general ultrasound studies. Its primary modes of operation are: B-Mode. M-Mode, Multi View (MView), Amplitude Doppler (AD), Tissue Velocity Mapping (TVM) and Tissue Enhancement Imaging (TEI). Optional is Doppler and Color Flow Mapping (CFM). The MyLabFive is equipped with a LCD Color Display. The full alphanumeric keyboard allows complete on-screen data entry of patient information and on-screen annotations. The MyLabFive can drive phased (PA), convex (CA), linear array (LA) and Doppler probes.

The MyLabFive is equipped with an internal Hard Disk and with an optional external DVD-RW disk drive that can be used for image storage. Data can also be stored directly to external archiving media (hard-disk, PC, server) via a LAN/USB port. Optional accessory devices available for the MyLabFive include an S-VHS video recorder, a monochrome or color page printer and a mobile trolley equipped with an insulation transformer.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Ultrasonic

Anatomical Site

Cardiac, Transesophageal, Peripheral Vascular, Neonatal Cephalic, Adult Cephalic, Small organ, Musculoskeletal (Conventional and Superficial), Abdominal, Fetal, Transvaginal, Transrectal, Pediatric, Laparoscopic, Intraoperative Abdominal, Urologic, Breast, Thyroid, Testicles

Indicated Patient Age Range

Adult, Pediatric, Neonatal, Fetal

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K070903, K081794

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 892.1550 Ultrasonic pulsed doppler imaging system.

(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.

0

510(k) Summary MyLabFive Esaote Europe

K0r3882

JAN 8 0 2009

510(k) Summary

The following 510(k) summary has been prepared pursuant to requirements specified in 21CFRf807.92(a).

807.92(a)(1)

Submitter Information

Jamie Austin Anson Group 11460 N. Meridian St., Ste. 150 Carmel, IN 46032 Phone: (317) 569-9500 x 118 Facsimile: (317) 569-9520

Contact Person: Jamie Austin

Date: December 10, 2008

807.92(a)(2)

Trade Name: MyLabFive Ultrasound System

Common Name: Ultrasound Imaging System

Classification Name(s):

Ultrasonic pulse Doppler imaging system892.1550
Ultrasonic pulsed echo imaging system892.1560
Diagnostic ultrasonic transducer892.1570

Classification Number: 90IYN, 90IYO, 90ITX


1

510(k) Summary MyLabFive Esaote Europe

807.92(a)(3)
Predicate Device(s)
K0709032750 (MyLab40)Esaote Europe
K0817947340 (MyLab30 Gold Cardiovascular)Esaote S.p.A.

Additional substantial equivalence information is provided in the following substantial equivalence comparison table.

807.92 (a)(4)

Device Description

The MyLabFive is a portable ultrasound system used to perform diagnostic general ultrasound studies. Its primary modes of operation are: B-Mode. M-Mode, Multi View (MView), Amplitude Doppler (AD), Tissue Velocity Mapping (TVM) and Tissue Enhancement Imaging (TEI). Optional is Doppler and Color Flow Mapping (CFM). The MyLabFive is equipped with a LCD Color Display. The full alphanumeric keyboard allows complete on-screen data entry of patient information and on-screen annotations. The MyLabFive can drive phased (PA), convex (CA), linear array (LA) and Doppler probes.

The MyLabFive is equipped with an internal Hard Disk and with an optional external DVD-RW disk drive that can be used for image storage. Data can also be stored directly to external archiving media (hard-disk, PC, server) via a LAN/USB port. Optional accessory devices available for the MyLabFive include an S-VHS video recorder, a monochrome or color page printer and a mobile trolley equipped with an insulation transformer.

807.92(a)(5)

Intended Use(s)

Esaote's MyLabFive is a compact ultrasound system used to perform diagnostic general ultrasound studies including Cardiac, Transesophageal, Peripheral Vascular, Neonatal Cephalic, Adult Cephalic, Small organ, Musculoskeletal (Conventional and Superficial). Abdominal, Fetal, Transvaginal, Transrectal, Pediatric, Laparoscopic, Intraoperative Abdominal, and Other Urologic. The system provides imaging for guidance of biopsy and imaging to assist in the placement of needles and catheters in vascular or other anatomical structures as well as peripheral nerve blocks in Musculoskeletal applications.

2

510(k) Summary MyLabFive Esaote Europe

807.92(a)(6)

Esaote believes that the MyLabFive is substantial equivalent to the Esaote MyLab30 Gold Cardiovascular product (K081794) and Esaote MyLab40 product (K070903).

  • · The MyLabFive represents an evolution of the ESAOTE Europe MyLab40 system with regard to the technical capabilities: most of the hardware architecture is the same, the software driving the device is the same, the optional trolley providing an insulation transformer for safe peripherals connection are comparable to the trolley of the ESAOTE Europe MyLab40.
  • · Clinical uses for which the MyLabFive is designed are identical to those cleared for the ESAOTE MyLab40 via K070903.
  • · The MyLabFive Laparoscopic application makes use of the same design criteria of the ESAOTE 7340 (MyLab30 Gold Cardiovascular) cleared via K081794.
  • The MyLabFive, ESAOTE 7340 (MyLab30 Gold Cardiovascular) and the . ESAOTE Europe MyLab40 are designed to meet the IEC60601-1 and IEC60601-2-37 safety requirements.
  • · The MyLabFive, ESAOTE 7340 (MyLab30 Gold Cardiovascular) and the ESAOTE Europe MyLab40 provide an Acoustic Output Display feature per AIUM / NEMA standards, with equivalent Ispta and MI maximal values
  • · The MyLabFive, ESAOTE 7340 (MyLab30 Gold Cardiovascular) and the ESAOTE Europe MyLab40 provide a similar measurements and analysis package, with equal accuracy and precision.
  • · The MyLabFive, ESAOTE 7340 (MyLab30 Gold Cardiovascular) and the ESAOTE Europe MyLab40 have digital storage capabilities, including Network connectivity.
  • · Both the MyLabFive and the ESAOTE 7340 (MyLab30 Gold Cardiovascular) (K081794) are designed to be powered by battery when no main power is available.
  • · The MyLabFive MView mode is available on other FDA cleared ultrasound systems, for instance the Esaote Europe MyLab40 cleared via K070903.

3

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/3/Picture/1 description: The image shows a seal for the Department of Health & Human Services - USA. The seal is circular, with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. In the center of the seal is an emblem that appears to be an eagle or other bird-like figure.

Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Ésaote Europe, B.V. % Mr. Mark Job Responsible Third Party Official Regulatory Technology Services LLC 1394 25th Street NW BUFFALO MN 55313

JAN 30 2009

Re: K083882

Trade/Device Name: MyLabFive Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: II Product Code: IYN, IYO, and ITX Dated: January 14, 2009 Received: January 15, 2009

Dear Mr. Job:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual i registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

This determination of substantial equivalence applies to the following transducers intended for use with the MyLabFive, as described in your premarket notification:

Transducer Model Number

PA230 PA122 LA332 LA523P C5-2 R13 CA123 CA631 2 CW 5 CW

4

EC1123
TRT33
TEE022
TEE122
IOE323
LP323
I-5PA

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrl/industry/support/index.html

If you have any questions regarding the content of this letter, please contact Lauren Hefner at (240) 276-3666.

Sincerely yours,

Vogue Mitha

A Janine M. Morris Acting Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure(s)

5

Indications for Use

510(k) Number (if known):

Device Name: MyLabFive

Esaote's MyLabFive is a compact ultrasound system used to perform diagnostic general ultrasound studies including Cardiac, Transesophageal, Peripheral Vascular, Neonatal Cephalic, Adult Cephalic, Small organ, Musculoskeletal (Conventional and Superficial), Abdominal, Fetal, Transvaginal, Transrectal, Pediatric, Laparoscopic, Intraoperative Abdominal, and Other Urologic. The system provides imaging for guidance of biopsy and imaging to assist in the placement of needles and catheters in vascular or other anatomical structures as well as peripheral nerve blocks in Musculoskeletal applications.

Prescription Use (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)


(Division Sign-Off)

Division of Reproductive, Abdominal and Radiological Devices 510(k) Number

Page 1 of 1

Prescription Use (Per 21 CFR 801.109)

6

MyLabFive

Clinical ApplicationBMPWDCWDColor DopplerAmplitude DopplerCombined [3]TVMTissue Enhancement Imaging (TEI)Other (specify)
OphthalmicNNNN5, 6, 7
FetalNNNNNNNN5, 6
AbdominalNNNNNNNN5, 6, 10
Intraoperative (Abdominal)NNNNNNNN
Intraoperative Neurological
PediatricNNNNNNNN5, 6, 10
Small Organ [1]NNNNNNNN4, 5, 6, 10
Neonatal CephalicNNNNNNNN5, 6
Adult CephalicNNNNNNNN6
Cardiac [2]NNNNNNNNN4, 6, 8, 9
Transesophageal (Cardiac)NNNNNNNNN4, 6, 8, 9
Transesophageal (Non Cardiac)
TransrectalNNNNNNNN5, 6, 10
TransvaginalNNNNNNNN5, 6
Transurethral
Intravascular
Peripheral VascularNNNNNNNN5, 6, 7, 9, 10
LaparoscopicNNNNNNNN5, 6, 10
Musculo-skeletal Conventional
(including Nerve Blocking)NNNNNNNN4, 5, 6, 10
Musculo-skeletal Superficial
(including Nerve Blocking)NNNNNNNN4, 5, 6, 10
Other (Urological)NNNNNNNN5, 6

(미 지 [기 (4) [5] ામ ছে ব্রিটিশন করে পারে।
প্রশ্ন থেকে বিশ্রাম বিশ্বের প্রায় প্রশ্ন করে বিশ্রাম বিশ্বের প্রায় প্রশ্ন করে প্রশ্ন করে প্রায় করে প্রশ্ন করে প্রযুক্তি করে পারে পারে পারে পারে পারে (9)

(10)

Small Organs includes Breast, Thyroid and Testicles Cardiac is Adult and Pediatric Combined modes are: B + M + PW + CW + CPM + PD СМЫ MVicw XView

QIMT Stress Strain TP View

Prescription Use
(Per 21 CFR 801.109)

Avram M. White

(Division Sign-Off) Division of Reproductive, Abdominat and Radiological Devices 510(k) Number _

7

Clinical ApplicationMode of Operations
BMPWDCWDColor.
DopplerAmplitude
DopplerCombined
[3]TVMTissue
Enhancement
Imaging (TEI)Other (specify)
Ophthalmic
Fetal
AbdominalPPPPPPPP6
Intraoperative (Abdominal)
Intraoperative Neurological
Pediatric
Small Organ [1]
Neonatal Cephalic
Adult CephalicPPPPPPPP6
Cardiac [2]PPPPPPPPP4, 6, 8, 9
Transesophageal (Cardiac)
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral Vascular
Laparoscopic
Musculo-skeletal Conventional
(including Nerve Blocking)
Musculo-skeletal Superficial (including
Nerve Blocking)
Other (Urological)

PA230

The PA230 probe was previously cleared

via K070903 (1)

(2) (3) কি (리 ાંદો [7] (8) lal

(10)

Small Organs includes Breast, Thyroid and Testicles Cardiac is Adult and Pediatric Combined modes are: B + M + PW + CW + CFM + PD смм MVicw XView QIMT gress 8train TP View

Prescription Use (Per 21 CFR 801.109)

Vorzu hith

(Division Bign-Off) Division of Reproductive, Abdominal and Radiological Devices 510(k) Number

.

6

8

PA122

| Clinical Application | B | M | PWD | CWD | Color
Doppler | Amplitude
Doppler | Combined [3] | TVM | Tissue
Enhancement
Imaging (TEI) | Other (specify) |
|-------------------------------------------------------------|---|---|-----|-----|------------------|----------------------|--------------|-----|----------------------------------------|-----------------|
| Ophthalmic | | | | | | | | | | |
| Fetal | | | | | | | | | | |
| Abdominal | | | | | | | | | | |
| Intraoperative (Abdominal) | | | | | | | | | | |
| Intraoperative Neurological | | | | | | | | | | |
| Pediatric | P | P | P | P | P | P | P | | P | 6 |
| Small Organ [1] | | | | | | | | | | |
| Neonatal Cephalic | P | P | P | P | P | P | P | | P | 6 |
| Adult Cephalic | | | | | | | | | | |
| Cardiac [2] | P | P | P | P | P | P | P | P | P | 4, 6, 8, 9 |
| Transesophageal (Cardiac) | | | | | | | | | | |
| Transesophageal (Non Cardiac) | | | | | | | | | | |
| Transrectal | | | | | | | | | | |
| Transvaginal | | | | | | | | | | |
| Transurethral | | | | | | | | | | |
| Intravascular | | | | | | | | | | |
| Peripheral Vascular | P | P | P | P | P | P | P | | P | 6, 9 |
| Laparoscopic | | | | | | | | | | |
| Musculo-skeletal Conventional
(including Nerve Blocking) | | | | | | | | | | |
| Musculo-skeletal Superficial
(including Nerve Blocking) | | | | | | | | | | |
| Other (Urological) | | | | | | | | | | |

cleared via K070903

[피

(기

(3)

(ન)

ទ្រ

[기

(8)

lal

l 10/

. '

.

Small Organs includes Breast, Thyroid and Testicles Cardiac is Adult and Pediatric Combined modes are: B + M + PW + CW + CW + CFM + PD СМЫ MVlew XVicw : QINT Stress Strain TP View

(Division Sign-Off)

Prescription Use . (Per 21 CFR 801.109)

Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number K083882

L

9

LA332

| Clinical Application | B | M | PWD | CWD | Color
Doppler | Amplitude
Doppler | Combined
[3] | TVM | Tissue
Enhancement
(Imaging (TEI) | Other (specify) |
|-------------------------------------------------------------|---|---|-----|-----|------------------|----------------------|-----------------|-----|-----------------------------------------|-----------------|
| Ophthalmic | | | | | | | | | | |
| Fetal | | | | | | | | | | |
| Abdominal | | | | | | | | | | |
| Intraoperative (Abdominal) | | | | | | | | | | |
| Intraoperative Neurological | | | | | | | | | | |
| Pediatric | P | P | P | | P | P | P | | P | 5, 6, 10 |
| Small Organ [1] | P | P | P | | P | P | P | | P | 4, 5, 6, 10 |
| Neonatal Cephalic | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | |
| Cardiac [2] | | | | | | | | | | |
| Transesophageal (Cardiac) | | | | | | | | | | |
| Transesophageal (Non Cardiac) | | | | | | | | | | |
| Transrectal | | | | | | | | | | |
| Transvaginal | | | | | | | | | | |
| Transurethral | | | | | | | | | | |
| Intravascular | | | | | | | | | | |
| Peripheral Vascular | P | P | P | | P | P | P | | P | 5, 6, 7, 9, 10 |
| Laparoscopic | | | | | | | | | | |
| Musculo-skeletal Conventional
(including Nerve Blocking) | P | P | P | | P | P | P | | P | 4, 5, 6, 10 |
| Musculo-skeletal Superficial
(including Nerve Blocking) | P | P | P | | P | P | P | | P | 4, 5, 6, 10 |
| Other (Urological) | | | | | | | | | | |

The LA332 probe was previously cleared via K081794

(1) (2)

(3) [4]

(5)

ાં રા

ரி

(8)

(의

|10|

Small Organs includes Breast, Thyroid and Testicles Cardiac is Adult and Pediatric Combined modes are: B + M + PW + CW + CFM + PD CMM MVicw XView QIMT 84ess Strain TP View

(Division Sign-Off)

Division of Reproductive, Abdominal and Radiological Devices 510(k) Number 83882

Prescription Use (Per 21 CFR 801.109)

.

L

10

LA523P

Clinical ApplicationMode of OperationsOther (specify)
BMPWDCWDColor
DopplerAmplitude
DopplerCombined
[3]TVMTissue
Enhancement
Imaging (TEI)
Ophthalmic
Fetal
Abdominal
Intraoperative (Abdominal)
Intraoperative Neurological
PediatricPPPPPPP5, 6, 10
Small Organ [1]PPPPPPP4, 5, 6, 10
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Transesophageal (Cardiac)
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
intravascular
Peripheral VascularPPPPPPP5, 6, 7, 9, 10
Laparoscopic
Musculo-skeletal Conventional
(including Nerve Blocking)PPPPPPP4,5,6,10
Musculo-skeletal Superficial
(including Nerve Blocking)PPPPPPP4, 5, 6, 10
Other (Urological)
[1]Small Organs includes Breast, Thyroid and Testicles
[2]Cardiac is Adult and Pediatric
[3]Combined modes are: B + M + PW + CW + CFM + PD
[4]CMM
[5]MView
[6]XView
[7]QIMT
[8]Stress
[9]Strain
[10]TP View

Amym M. Wha

Prescription Use
(Per 21 CFR 801.109)

L

(Division Sign-Off) Division of Reproductive, Abdominal and Radiological Devices 510(k) Number _ 887

MyLabFive 510(k) December 2008

.

·

11

Clinical ApplicationMode of Operations
BMPWDCWDColor
DopplerAmplitude
DopplerCombined
[3]TVMTissue
Enhancement
Imaging (TEI)Other (specify)
Ophthalmic
FetalPPPPPPP5, 6, 7
AbdominalPPPPPPP5, 6
Intraoperative (Abdominal)
Intraoperative Neurological
PediatricPPPPPPP5,6
Small Organ [1]
Neonatal CephalicPPPPPPP5, 6
Adult Cephalic
Cardiac (2)
Transesophageal (Cardiac)
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral VascularPPPPPPP5, 6, 9
Laparoscopic
Musculo-skeletal Conventional
(including Nerve Blocking)
Musculo-skeletal Superficial
(including Nerve Blocking)
Other (Urological)

The CS-2 probe was ps evious

(1) (기 (ગ ામ ([[[] (6) [기 ાં જો ાં છે. 110)

.

Small Organs includes Breast, Thyroid and Testicles Cardiac is Adult and Pediatric Combined modes are: B + M + PW + CW + CFM + PD CMM MView . XView ਼ੀਆ

Streess

Strain

TP Vlew

Aoyu In Whang

(Division Sign-Off) Division of Reproductive, Abdominal and Radiological Devices 083882 510(k) Number

Prescription Use
(Per 21 CFR 801.109)

12

CA123

| Clinical Application | B | M | PWD | CWD | Color
Doppler | Amplitude
Doppler | Combined
[3] | TVM | Tissue
Enhancement
Imaging (TEI) | Other (specify) |
|-------------------------------------------------------------|---|---|-----|-----|------------------|----------------------|-----------------|-----|----------------------------------------|-----------------|
| Ophthalmic | | | | | | | | | | |
| Fetal | | | | | | | | | | |
| Abdominal | | | | | | | | | | |
| Intraoperative (Abdominal) | | | | | | | | | | |
| Intraoperative Neurological | | | | | | | | | | |
| Pediatric | P | P | P | | P | P | P | | P | 5, 6 |
| Small Organ [1] | P | P | P | | P | P | P | | P | 4,5,6 |
| Neonatal Cephalic | P | P | P | | P | P | P | | P | 5, 6 |
| Adult Cephalic | | | | | | | | | | |
| Cardiac [2] | P | P | P | | P | P | P | | P | 4, 5, 6 |
| Transesophageal (Cardiac) | | | | | | | | | | |
| Transesophageal (Non Cardiac) | | | | | | | | | | |
| Transrectal | | | | | | | | | | |
| Transvaginal | | | | | | | | | | |
| Transurethral | | | | | | | | | | |
| Intravascular | | | | | | | | | | |
| Peripheral Vascular | P | P | P | | P | P | P | | P | 5,6, 9 |
| Laparoscopic | | | | | | | | | | |
| Musculo-skeletal Conventional
(including Nerve Blocking) | P | P | P | | P | P | P | | P | 4, 5, 6 |
| Musculo-skeletal Superficial
(including Nerve Blocking) | P | P | P | | P | P | P | | P | 4, 5, 6 |
| Other (Urological) | | | | | | | | | | |

The CA123 probe was

[1] 기 (3) ામ ાંગ િશ [기 (8) la) | 10|

XView

QIMT

Stress

Strain

TP View

Small Organs includes Breast, Thyroid and Testicles Cardiac is Adult and Pediatric Combined modes are: B + M + PW + CW + CW + CPM + PD смм MVicw

(a

(Division Sign-Off) Division of Reproductive, Abdominal and Radiological Devices 085882 510(k) Number

Prescription Use (Per 21 CFR 801.109)

13

Mode of Operations
Clinical ApplicationBMPWDCWDColor
DopplerAmplitude
DopplerCombined
[3]TVMTissue
Enhancement
Imaging (TEI)Other (specify)
Ophthalmic
FetalPPPPPPP5,6,7
AbdominalPPPPPPP5,6
Intraoperative (Abdominal)
Intraoperative Neurological
PediatricPPPPPPP5,6
Small Organ [1]
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Transesophageal (Cardiac)
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral VascularPPPPPPP5,6,9
Laparoscopic
Musculo-skeletal Conventional
(including Nerve Blocking)PPPPPPP4,5,6
Musculo-skeletal Superficial
(including Nerve Blocking)PPPPPPP4,5,6
Other (Urological)PPPPPPP5,6

The CA631 probe was
cleared via K070903 previously

  • [1] . (기 [3] િની (왕) ાંઠા (ग ામાં lal ( ol
    Small Organs includes Breast, Thyroid and Testicles Cardiac is Adult and Pediatric Combined modes are: B + M + PW + CW + CFM + PD CMM NVicw

XView

QIMT

8tress

Strain

TP Vlew

Tony M. White


(Division Sign Off)

Prescription Use (Per 21 CFR 801.109)

Division of Reproductive, Abdominal and Radiological Devices 510(k) Number _

CA631

:

. .

14

2 CW
0.00
Clinical ApplicationBMPWDCWDColor DopplerAmplitude DopplerCombined [3]TVMTissue Enhancement Imaging (TEI)Other (specify)
Ophthalmic
Fetal
Abdominal
Intraoperative (Abdominal)
Intraoperative Neurological
Pediatric
Small Organ [1]
Neonatal Cephalic
Adult Cephalic
Cardiac [2]P
Transesophageal (Cardiac)
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral Vascular
Laparoscopic
Musculo-skeletal Conventional
(including Nerve Blocking)
Musculo-skeletal Superficial
(including Nerve Blocking)
Other (Urological)

The 2Cw probe was p GAIDULTI

[1]Small Organs includ
[2]Cardiac is Adult and
[3]Combined modes an
[4]CMM
[5]MView
[6]XView
[7]QIMT
[8]Stress
[9]Strain
[10]TP View

des Breast, Thyroid and Testicles d Pediatric re: B + M + PW + CW + CW + CPM + PD

Division Sign Org

(Division Sign-Off) V Division of Reproductive, Abdominal and Radiological Devices 083882 510(k) Number _

Prescription Use (Per 21 CFR 801.109)

.

e.

15

Mode of Operations
Clinical ApplicationBMPWDCWDColor
DopplerAmplitude
DopplerCombined
TVM (3)Tissue
Enhancement
Imaging (TEI)Other (specify)
Ophthalmic
Fetal
Abdominal
Intraoperative (Abdominal)
Intraoperative Neurological
Pediatric
Small Organ (1)
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Transesophageal (Cardiac)
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral VascularP
Laparoscopic
Musculo-skeletal Conventional
(including Nerve Blocking)
Musculo-skeletal Superficial
(including Nerve Blocking)
Other (Urological)

The SCW probe was previously

cleared via K070903
[1]Small Organs includes Breast, Thyroid and Testicles
[2]Cardiac is Adult and Pediatric
[3]Combined modes are: B + M + PW + CW + CFM + PD
[4]CMM
[5]MView
[6]XView
[7]QIMT
[8]Stress
[9]Strain
[10]TP View

Sonny Weaver

Prescription Use (Per 21 CFR 801.109)

1

(División Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number K083882

.

16

EC1123

Mode of Operations
Clinical ApplicationBMPWDCWDColor
DopplerAmplitude
DopplerCombined
[3]TVMTissue
Enhancement
Imaging (TEI)Other (specify)
Ophthalmic
FetalPPPPPPP5,6,7
Abdominal
Intraoperative (Abdominal)
Intraoperative Neurological
Pediatric
Small Organ [1]
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Transesophageal (Cardiac)
Transesophageal (Non Cardiac)
TransrectalPPPPPPP5,6
TransvaginalPPPPPPP5,6
Transurethral
Intravascular
Peripheral Vascular
Laparoscopic
Musculo-skeletal Conventional
(including Nerve Blocking)
Musculo-skeletal Superficial
(including Nerve Blocking)
Other (Urological)PPPPPPP5,6

cleared via K081794

. (1) (2) [3] [ፈር (ട) (6)

। ਸ

(8)

ીકો

[10]

.

Small Organs includes Breast, Thyroid and Testicles Cardiac is Adult and Pediatric

Combined modes are: B + M + PW + CW + CFM + PD

CMM MView XVicw QIMT இருக்க Strain

TP View

Arra In Wha

Prescription Use (Per 21 CFR 801.109)

. .

.

(Division Sign-Off) Division of Reproductive, Abdominal and Radiological Devices 082882 510(k) Number

17

TRT33

Mode of Operations
Clinical ApplicationBMPWDCWDColor
DopplerAmplitude
DopplerCombined
[3]TVMTissue
Enhancement
Imaging (TEI)Other (specify)
Ophthalmic
Fetal
Abdominal
Intraoperative (Abdominal)
Intraoperative Neurological
Pediatric
Small Organ [1]
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Transesophageal (Cardiac)
Transesophageal (Non Cardiac)
TransrectalPPPPPPPP5,6,10
Transvaginal
Transurethral
Intravascular
Peripheral Vascular
Laparoscopic
Musculo-skeletal Conventional
(including Nerve Blocking)
Musculo-skeletal Superficial
(including Nerve Blocking)
Other (Urological)PPPPPPPP5, 6, 10

The TRT33 probe was previously

cleared via K081794 [1]

(2)

િંગ્લ ાં ના

ાજી

ાંધા

11

ម្រៀ

(9)

(10)

.

Small Organs includes Breast, Thyroid and Testicles Cardiac is Adult and Pediatric Combined modes are: B + M + PW + CW + CFM + PD CMM MVlew XVicw QIMT Stress Strain TP View

Lorri M. Wertz

Prescription Use
(Per 21 CFR 801.109)

(Division Sign-Off) Division of Reproductive, Abdominal and Radiological Devices 083882 510(k) Number

18

TEE022

Mode of Operations
Clinical ApplicationBMPWDCWDColor
DopplerAmplitude
DopplerCombined
[3]TVMTissue
Enhancement
Imaging (TEI)Other (specify)
Ophthalmic
Fetal
Abdominal
Intraoperative (Abdominal)
Intraoperative Neurological
Pediatric
Small Organ [1]
Neonatal Cephalic
Adult Cephalic
Cardiac (2)
Transesophageal (Cardiac)PPPPPPPPP4, 6, 8, 9
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral Vascular
Laparoscopic
Musculo-skeletal Conventional
(including Nerve Blocking)
Musculo-skeletal Superficial
(including Nerve Blocking)
Other (Urological)

The TEEO22 probe was previously
cleared via K070903

(ப

(2)

ાંચા

(ના

(5)

[6]

[7]

(8)

(ત્રા

(10)

Small Organs includes Breast, Thyroid and Testicles Cardiac is Adult and Pediatric Combined modes are: B + M + PW + CW + CW + CFM + PD cmm MVièw XVicw QIMT 8tress Strain TP View

Lorna M. Wilson

Preseription Use _____________________________________________________________________________________________________________________________________________________________ Per 21 CFR 801.109)

(Division Sign-Off) Division of Reproductive, Abdominal and Radiological Devices 510(k) Number _

. V

19

TEE122

:

Mode of Operations
Clinical ApplicationBMPWDCWDColor
DopplerAmplitude
DopplerCombined
[3]TVMTissue
Enhancement
Imaging (TEI)Other (specify)
Ophthalmic
Fetal
Abdominal
Intraoperative (Abdominal)
Intraoperative Neurological
Pediatric
Small Organ [1]
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Transesophageal (Cardiac)PPPPPPPPP4, 6, 8, 9
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral Vascular
Laparoscopic
Musculo-skeletal Conventional
(including Nerve Blocking)
Musculo-skeletal Superficial
(including Nerve Blocking)
Other (Urological)

The TEE122 probe was previously
cleared via K070903

|||

(기

(3)

(4)

[의

[6]

្រប

[8]

lal

[1이

CMM MView XView QIMT

Small Organs includes Breast, Thyroid and Testicles Cardiac is Adult and Pediatric Combined modes are: B + M + PW + CW + CFM + PD Stress Strain TP View

forne In Wha

Prescription Use (Per 21 CFR 801.109)

L

(Division Sign-Off) Division of Reproductive, Abdominal and Radiological Devices 083882 510(k) Number _

20

IOE323

| Clinical Application | B | M | PWD | CWD | Color
Doppler | Amplitude
Doppler | Combined
(3) | TVM | Tissue
Enhancement
Imaging (TEI) | Other (specify) |
|-------------------------------------------------------------|---|---|-----|-----|------------------|----------------------|-----------------|-----|----------------------------------------|-----------------|
| Ophthalmic | | | | | | | | | | |
| Fetal | | | | | | | | | | |
| Abdominal | P | P | P | | P | P | P | | P | 5, 6, 10 |
| Intraoperative (Abdominal) | P | P | P | | P | P | P | | P | 5, 6, 10 |
| Intraoperative Neurological | | | | | | | | | | |
| Pediatric | P | P | P | | P | P | P | | P | 5,6,10 |
| Small Organ [1] | P | P | P | | P | P | P | | P | 4, 5, 6, 10 |
| Neonatal Cephalic | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | |
| Cardiac (2) | | | | | | | | | | |
| Transesophageal (Cardiac) | | | | | | | | | | |
| Transesophageal (Non Cardiac) | | | | | | | | | | |
| Transrectal | | | | | | | | | | |
| Transvaginal | | | | | | | | | | |
| Transurethral | | | | | | | | | | |
| Intravascular | | | | | | | | | | |
| Peripheral Vascular | P | P | P | | P | P | P | | P | 5, 6, 9, 10 |
| Laparoscopic | | | | | | | | | | |
| Musculo-skeletal Conventional
(including Nerve Blocking) | P | P | P | | P | P | P | | P | 4, 5, 6, 10 |
| Musculo-skeletal Superficial
(including Nerve Blocking) | P | P | P | | P | P | P | | P | 4, 5, 6, 10 |
| Other (Urological) | | | | | | | | | | |

ﻨﺎ ﺍﻟﻤﺘﺎﺯ cleared via K070903

(1) [2| (३) (4| (SI િકા (7) (8) ાં છે (10)

Small Organs includes Breast, Thyroid and Testicles Cardiac is Adult and Pediatric Combined modes are: B + M + PW + CW + CFM + PD CMM MView XVicw QIMT Stress Strain TP View

(Division Sign-Off)

Division of Reproductive, Abdominal and Radiological Devices 510(k) Number

Prescription Use _ . (Per 21 CFR 801.109)

.

21

LP323

Mode of Operations
Clinical ApplicationBMPWDCWDColor
DopplerAmplitude
DopplerCombined
[3]TVMTissue
Enhancement
Imaging (TEI)Other (specify)
Ophthalmic
Fetal
AbdominalPPPPPPP5, 6, 10
Intraoperative (Abdominal)
Intraoperative Neurological
Pediatric
Small Organ [1]
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Transesophageal (Cardiac)
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral Vascular
LaparoscopicPPPPPPP5, 6, 10
Musculo-skeletal Conventional
(including Nerve Blocking)
Musculo-skeletal Superficial
(including Nerve Blocking)
Other (Urological)

The LP323 probe was previously
cleared via K051837 & K081794

(1) (외 (3) (4) (ខ) ાઠા [기 [8] al | 10|

Small Organs includes Breast, Thyroid and Testicles Cardiac is Adult and Pediatric Combined modes are: B + M + PW + CW + CFM + PD વખત MView XVicw QIMT

Stress

Straim

TP View

:

Arndt De Witte

Prescription Use
(Per 2.1 CFR 801.109)

. ﺮ ﺍﻟﻤﺮﺍﺟﻊ

(Division Sign-Off) (Division of Reproductive, Abdominal and Radiological Devices 510(k) Number

.

22

| Clinical Application | B | M | PWD | CWD | Color
Doppler | Amplitude
Doppler | Combined
[3] | TVM | Tissue
Enhancement
Imaging (TEI) | Other (specify) |
|-------------------------------------------------------------|---|---|-----|-----|------------------|----------------------|-----------------|-----|----------------------------------------|-----------------|
| Ophthalmic | | | | | | | | | | |
| Fetal | | | | | | | | | | |
| Abdominal | N | N | N | N | N | N | N | | N | 6 |
| Intraoperative (Abdominal) | | | | | | | | | | |
| Intraoperative Neurological | | | | | | | | | | |
| Pediatric | | | | | | | | | | |
| Small Organ [1] | | | | | | | | | | |
| Neonatal Cephalic | | | | | | | | | | |
| Adult Cephalic | N | N | N | N | N | N | N | | N | 6 |
| Cardiac (2) | N | N | N | N | N | N | N | N | N | 4, 6, 8, 9 |
| Transesophageal (Cardiac) | | | | | | | | | | |
| Transesophageal (Non Cardiac) | | | | | | | | | | |
| Transrectal | | | | | | | | | | |
| Transvaginal | | | | | | | | | | |
| Transurethral | | | | | | | | | | |
| Intravascular | | | | | | | | | | |
| Peripheral Vascular | | | | | | | | | | |
| Laparoscopic | | | | | | | | | | |
| Musculo-skeletal Conventional
(including Nerve Blocking) | | | | | | | | | | |
| Musculo-skeletal Superficial (including
Nerve Blocking) | | | | | | | | | | |
| Other (Urological) | | | | | | | | | | |

he 1-5PA pro

submasion

(1) (2) (3) [4] (5) (6) (7) ម្រៀ છી || 이 Small Organs includes Breast, Thyroid and Testicles Cardiac is Adult and Pediatric Combined modes are: B + M + PW + CW + CFM + PD cmn MVicw .XView QIMT ' Stress Strain TP View

Roger M. Wern

Prescription Use J (Per 21 CFR 801.109)

L

(Division Sign-Off) 0 Division of Reproductive, Abdominal and Radiological Devices 510(k) Number _